Eunchong Park

Eunchong Park

Auto-generated profile, based on publicly available information

Eunchong Park

Bioscience Immunology, Research and Early Development, Respiratory and Immunology, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
EPEunchong Park
Eunchong Park
MCMaria Ciofani
Maria Ciofani
T helper 17 (Th17) cells have been implicated in numerous inflammatory autoimmune diseases. Clinical benefits from targeting Th17 cell-related cytokines, such as IL-17 and IL-23, highlight how knowledge of Th17 cell development and effector function can be translated into treatments for inflammatory disease. Here we discuss the pathogenic roles of Th17 cells in autoimmune diseases such as multiple sclerosis, inflammatory bowel disease and psoriasis, with emphasis on the cytokines, transcriptional regulators and metabolites that influence Th17 cell differentiation and pathogenicity. Moreover, we address how intestinal environments and physiological responses affect Th17 cells in autoimmune diseases. We also examine current and emerging therapeutic strategies aimed at regulating Th17 cell-driven inflammation to mitigate autoimmune diseases.

27 October 2023 in Science Immunology
Verified
Journal Article
Closed access
EPEunchong Park
Eunchong Park
WBWilliam E. Barclay
William E. Barclay
ABAlejandro Barrera
Alejandro Barrera
TLTzu-Chieh Liao
Tzu-Chieh Liao
HSHarmony R. Salzler
Harmony R. Salzler
MCMaria Ciofani
Maria Ciofani
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) caused by CNS-infiltrating leukocytes, including T H 17 cells that are critical mediators of disease pathogenesis. Although targeting leukocyte trafficking is effective in treating autoimmunity, there are currently no therapeutic interventions that specifically block encephalitogenic T H 17 cell migration. Here, we report integrin α3 as a T H 17 cell–selective determinant of pathogenicity in experimental autoimmune encephalomyelitis. CNS-infiltrating T H 17 cells express high integrin α3, and its deletion in CD4 + T cells or Il17a fate-mapped cells attenuated disease severity. Mechanistically, integrin α3 enhanced the immunological synapse formation to promote the polarization and proliferation of T H 17 cells. Moreover, the transmigration of T H 17 cells into the CNS was dependent on integrin α3, and integrin α3 deficiency enhanced the retention of CD4 + T cells in the perivascular space of the blood-brain barrier. Integrin α3–dependent interactions continuously maintain T H 17 cell identity and effector function. The requirement of integrin α3 in T H 17 cell pathogenicity suggests integrin α3 as a therapeutic target for MS treatment.

22 March 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
GSGregory Swan
Gregory Swan
JGJia Geng
Jia Geng
EPEunchong Park
Eunchong Park
QDQuanquan Ding
Quanquan Ding
JZJohn Zhou
John Zhou
DWDonghai Wang
Donghai Wang
Precisely controlled lymphocyte migration is critically required for immune surveillance and successful immune responses. Lymphocyte migration is strictly regulated by chemokines and chemokine receptors. Here we show that protein geranylgeranylation, a form of post-translational protein lipid modification, is required for chemokine receptor-proximal signaling. Mature thymocytes deficient for protein geranylgeranylation are impaired for thymus egress. Circulating mature T cells lacking protein geranylgeranylation fail to home to secondary lymphoid organs or to transmigrate in response to chemokines in vitro. Mechanistically, protein geranylgeranylation modifies the γ-subunits of the heterotrimeric small GTPases that are essential for chemokine receptor signaling. In addition, protein geranylgeranylation also promotes the differentiation of IL-17-producing T helper cells while inhibiting the differentiation of Foxp3+ regulatory T cells. Finally, mice with T cell lineage-specific deficiency of protein geranylgeranylation are resistant to experimental autoimmune encephalomyelitis induction. This study elucidated a critical role of protein geranylgeranylation in regulating T lymphocyte migration and function.